SoftMaxx AI sells no peptides and takes no vendor money.
No supporting study We found no trial of biotinoyl tripeptide-1. The human studies we found test Procapil, a blend that includes biotinoyl tripeptide-1 as sellers describe it (none of the studies' abstracts lists its contents), together with platelet-rich plasma (PRP) or caffeine. In a 160-person non-randomized trial, PRP with a Procapil solution (strength in the doses table) scored better than PRP alone after 6 months; in a 54-man randomized trial, Procapil with PRP did worse than redensyl, saw palmetto and biotin with PRP.[1][2][3]
The tier describes the evidence for biotinoyl tripeptide-1 itself; the human studies here test Procapil, a blend that includes it as sellers describe it [1] [2] [3].
What Biotinoyl tripeptide-1 is
The EU cosmetic-ingredient database (CosIng) lists biotinoyl tripeptide-1 as 'the reaction product of Biotin and Tripeptide-1', with the function 'hair conditioning' [4]. A 2025 review lists Procapil among the most hyped topical hair actives [5]; none of the abstracts we read lists Procapil's ingredients.
- Expert review We found no peer-reviewed test of the mechanisms marketed for it. A 2025 review of the most hyped topical hair actives, Procapil among them, found the studies mostly small, tested in multi-ingredient formulas, rarely compared with standard therapies, and often with conflicts of interest [5]. A 2026 review describes short peptides as a promising approach for hair loss that has limitations [6].[5][6]
Claims vs. evidence
Each popular claim, graded by the strongest study behind it. The words in quotation marks are how the claim is marketed; the text after the grade is what the studies show.
- Claim as marketed
Reduces hair loss / improves androgenetic alopecia
Human, small or uncontrolled (Procapil data) The studies we found test Procapil together with PRP or caffeine; we found no study of biotinoyl tripeptide-1 itself, an ingredient of Procapil as sellers describe it, and none of the abstracts we read describes a placebo arm. In a 160-person non-randomized trial, PRP with a Procapil solution (strength in the doses table) scored better on dermatologist and patient ratings than PRP alone at 6 months; in a 54-man randomized trial, the comparison group (redensyl, saw palmetto and biotin, with PRP) did better than Procapil with PRP; a short report tested caffeine with Procapil.[2][1][3][5] - Claim as marketed
Anchors hair / strengthens follicle
No supporting study We found no peer-reviewed study testing this claim. A 2025 review of topical hair actives, Procapil among them, notes small studies, multi-ingredient formulas and conflicts of interest.[5] - Claim as marketed
Works as well as minoxidil
No supporting study We found no head-to-head trial against minoxidil or finasteride. In a meta-analysis of randomized trials, minoxidil (in men and in women) and 1 mg finasteride (in men) beat placebo.[7][8]
Common myths, checked
- Common belief
Procapil is a clinically proven natural alternative to minoxidil or finasteride.
Human RCT (Procapil data) We found no head-to-head trial against minoxidil or finasteride. The human studies we found test Procapil alongside PRP or caffeine, and in the one randomized trial we found, Procapil with PRP did worse than the comparison arm. A 2025 review notes small samples and little comparison with standard therapies.[2][1][5][7][3] - Common belief
Procapil blocks DHT.
No supporting study The abstracts of the human Procapil studies report hair ratings and photographs, not DHT or other hormones, and we found no study of Procapil or biotinoyl tripeptide-1 that measured DHT.[1][2] - Common belief
The biotin in it feeds your hair.
No supporting study CosIng lists biotinoyl tripeptide-1 as the reaction product of biotin and tripeptide-1 [4]. We found no study showing that this delivers a biotin effect to hair follicles.[6]
Doses used in studies (not a recommendation)
Each row comes from the cited source: a study dose, a safety-review limit or a registered trial's planned dose, as labelled. Where the abstract states no amount, the row says so. They are a record of what was reported, not dosing instructions, and nothing here says what you should take.
| Studied in | Route | Amount reported | How often | How long | n | Source |
|---|---|---|---|---|---|---|
| Humans | topical Procapil 5% solution + PRP | 5% Procapil Study dose | Procapil twice daily, plus PRP (4 sessions, 4 weeks apart, stated for the PRP-only group) | 6 months | 160 | [1] 160 patients with androgenetic alopecia (quasi-experimental, 80 per arm) |
| Humans | topical Procapil + PRP | Procapil concentration not stated in abstract Study dose | PRP every 3 weeks (4 sessions); Procapil schedule not stated in abstract | 4 PRP sessions at 3-week intervals (total length not stated in abstract) | 54 | [2] 54 men with androgenetic alopecia (RCT, 27 per arm) |
| Humans | topical caffeine + Procapil 3% | 3% Procapil Study dose | not characterised (short report without abstract) | not characterised | — | [3] men with pattern hair loss |
Side effects and risks
- Expert review A 2025 review describes these topical hair actives as having a less significant side-effect profile; we found no long-term safety study[5]
Regulatory status (checked 2026-10-01 to 2026-10-03)
- United States (FDA)We found no FDA-approved product containing biotinoyl tripeptide-1 in Drugs@FDA (searched 2026-10-01). (FDA:
Drugs@FDA search: biotinoyl-tripeptide-1 — no approved product found
, captured 2026-10-01) Under the FD&C Act, cosmetic products and ingredients, with the exception of color additives, do not require FDA approval before they go on the market; the Act defines drugs, in part, by their intended use, including “articles (other than food) intended to affect the structure or any function of the body of man or other animals”, and some products meet the definitions of both cosmetics and drugs. (FDA:Is It a Cosmetic, a Drug, or Both?
, captured 2026-10-03) - CanadaWe found no product containing biotinoyl tripeptide-1 in Health Canada’s Drug Product Database (searched 2026-10-01). (Health Canada:
Health Canada Drug Product Database search: biotinoyl-tripeptide-1 — no product found
, captured 2026-10-01) - Sport (WADA)WADA’s Prohibited List does not name biotinoyl tripeptide-1. WADA states that topical cosmetic products may contain prohibited peptides or growth factors and that using cosmetic products containing such substances is prohibited; we found no WADA statement on whether biotinoyl tripeptide-1 is one of them. (WADA:
World Anti-Doping Code International Standard Prohibited List 2026
, captured 2026-10-03; WADA:The Prohibited List
, captured 2026-10-03)
Official sources: FDA: Is It a Cosmetic, a Drug, or Both?
· WADA: World Anti-Doping Code International Standard Prohibited List 2026
· WADA: The Prohibited List
Report a side effect
If something went wrong after using a health product, tell a clinician. Report side effects to:
- FDA MedWatch (United States)
- Health Canada (report a side effect)
Common questions
Does procapil block DHT?
No supporting study The abstracts of the human Procapil studies report hair ratings and photographs, not DHT or other hormones, and we found no study of Procapil or biotinoyl tripeptide-1 that measured DHT.[1][2]
Procapil vs minoxidil?
No supporting study We found no head-to-head trial against minoxidil or finasteride. In a meta-analysis of randomized trials, minoxidil (in men and in women) and 1 mg finasteride (in men) beat placebo.[7][8]
Does procapil work?
Human, small or uncontrolled We found no trial of biotinoyl tripeptide-1. The human studies we found test Procapil, a blend that includes biotinoyl tripeptide-1 as sellers describe it (none of the studies' abstracts lists its contents), together with platelet-rich plasma (PRP) or caffeine. In a 160-person non-randomized trial, PRP with a Procapil solution (strength in the doses table) scored better than PRP alone after 6 months; in a 54-man randomized trial, Procapil with PRP did worse than redensyl, saw palmetto and biotin with PRP.[1][2][3]
References
References to papers were matched to their PubMed or DOI records. Regulator, label and registry pages were fetched and saved by us; each status line under Regulatory status gives the date its source was captured. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.
COMPARISON OF PLATELET RICH THERAPY ALONE WITH PLATELET RICH THERAPY ALONG WITH DAILY TOPICAL 5% PROCAPIL APPLICATION FOR THE TREATMENT OF ANDROGENETIC ALOPECIA.
PubMed 39609969 DOIA Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia.
PubMed 37292551 DOIAssessment of the efficacy and tolerability of a topical formulation containing caffeine and Procapil 3% for improvement of male pattern hair loss.
PubMed 37990760 DOIEU CosIng ingredient record: BIOTINOYL TRIPEPTIDE-1
SourceTopical Alternatives for Hair Loss: Beyond the Conventional.
PubMed 40654553 DOIOverview of Short Peptides for Hair Loss.
PubMed 42072405 DOIThe effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
PubMed 28396101 DOIRelative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
PubMed 35107565 DOI
Keep reading
- Peptides for hair growth vs minoxidil and finasteride→
- Peptides for looksmaxxing: what the evidence actually shows→
- AHK-Cu (alanyl-histidyl-lysine copper): what the evidence shows→
- Acetyl tetrapeptide-3 and Capixyl claims: what the evidence shows→
- GHK-Cu (copper tripeptide-1): what the evidence shows→
- All peptide pages, by evidence→